Jack Hoffman, a young man whose courageous battle with brain cancer and memorable touchdown run at a Nebraska football game touched hearts worldwide, passed away on January 15, 2025, at the age of 19.
Jack Hoffman’s Journey
Born in Atkinson, Nebraska, Jack was diagnosed with a brain tumor in 2011 at the age of five. Despite undergoing multiple surgeries and treatments, he remained resilient and hopeful. In 2013, during the Nebraska Cornhuskers’ spring game, seven-year-old Jack donned a No. 22 jersey and executed a 69-yard touchdown run, a moment that garnered national attention and earned the 2013 ESPY Award for Best Moment.
The Team Jack Foundation
Following Jack’s diagnosis, his family established the Team Jack Foundation to raise funds and awareness for pediatric brain cancer research. The foundation has since raised over $13 million, contributing significantly to advancements in treatment and support for affected families.
Andy Hoffman’s Battle
In July 2020, Jack’s father, Andy Hoffman, was diagnosed with glioblastoma, an aggressive form of brain cancer. A dedicated advocate for pediatric brain cancer research, Andy’s diagnosis was a profound blow to the family and the foundation’s community. He passed away on March 1, 2021, at the age of 42.
Continuing the Fight
Despite these personal tragedies, the Hoffman family’s commitment to combating brain cancer remains unwavering. The Team Jack Foundation continues to fund research initiatives, support clinical trials, and advocate for increased awareness and resources. Their efforts have not only honored Jack and Andy’s memories but have also provided hope and assistance to countless families facing similar battles.
A Legacy of Hope
Jack and Andy Hoffman’s stories have left an indelible mark on the fight against brain cancer. Their courage and advocacy have inspired a community dedicated to finding a cure and supporting those affected by the disease. The ongoing work of the Team Jack Foundation stands as a testament to their enduring legacy and the impact of their lives on the broader mission to end pediatric brain cancer.
